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Infection-induced inflammatory reactions in-
volve a strong increase in dendritic cells (DCs) at
the infection site and draining lymph nodes
(dLNs). Whether inflammatory DCs are recruited
to these locations or differentiate locally, and
what their functional relevance is, remain un-
clear. Here we showed that during Leishmania
infection, monocytes were recruited to the der-
mis and differentiated into ‘‘dermal monocyte-
derived DCs,’’ which subsequently migrated
into the dLNs. In addition, monocyte recruit-
ment to the dLNs resulted in the differentiation
into ‘‘LN monocyte-derived DCs.’’ Analysis of
the kinetics of monocyte differentiation into
DCs, susceptibility to infection, IL-12 produc-
tion, and L. major-specific T cell stimulation
potential suggest that dermal monocyte-
derived DCs controlled the induction of protec-
tive T helper 1 responses against Leishmania.
Thus, the demonstration of monocyte differen-
tiation potential into DCs during in vivo infection
and of local DC differentiation in inflammatory
foci suggests that de novo formed monocyte-
derived DCs are essential in T cell immunity
against pathogens.
INTRODUCTION
Recent research suggests that differentiation of conven-
tional dendritic cells (DCs), located in mucosal surfaces
and lymphoid organs, does not occur in the bone marrow,
but locally, in these peripheral locations (reviewed in Arda-
vin, 2003; Shortman and Naik, 2007). This hypothesis
relies on the fact that conventional DC subpopulations
existing in lymphoid and nonlymphoid organs are found
neither in the bone marrow nor in the blood and that DC
number increases considerably in the lymphoid organs
during infection; in addition, DC precursor populations
have been described in the circulation (reviewed in Arda-
vin, 2003). The concept of local DC differentiation impliesthe existence of circulating DC precursors that would be
recruited to peripheral antigen-capture locations and lym-
phoid organs, where theywould differentiate into DCs. Pe-
ripheral DC differentiation would therefore be responsible
for the maintenance of the different DC subsets existing
under steady state. A number of reports suggest that DC
precursor recruitment and de novo DC formation could
also take place in inflammatory foci and lymphoid organs
during infection (Martin et al., 2002; Serbina et al., 2003;
Yoneyama et al., 2001). Although different research
groups have addressed the identity of DC precursors
in steady state (reviewed in Shortman and Naik, 2007),
the characterization of DC precursors responsible for
de novo DC formation during infection has remained elu-
sive. Studies describing the accumulation of DCs in lym-
phoid tissues during infection or showing in noninfectious
inflammatory conditions that monocytes can differentiate
into DCs (Le Borgne et al., 2006; Geissmann et al., 2003;
Naik et al., 2006; Randolph et al., 1999; Serbina et al., 2003)
suggest that DC differentiation from monocytes could oc-
cur in vivo during infection. However, this hypothesis was
challenged by a report showing that monocyte differentia-
tion into DCs induced by subcutaneous (s.c.) injection of
latex microspheres was blocked if bacteria were present
in the injection area (Rotta et al., 2003).
In order to provide new insights on de novo DC differen-
tiation during in vivo infection, we used a murine experi-
mental model of cutaneous leishmaniasis induced by
Leishmania major (L. major) injection. Based on pheno-
typic studies, analysis of the kinetics of monocyte recruit-
ment and differentiation into DCs, and monocyte transfer
assays, our data demonstrate that during L. major infec-
tion, two de novo formed DC subsets were found in the
popliteal lymph nodes (PO-LNs). These included DCs
derived from monocytes recruited to the dermis that dif-
ferentiated locally and migrated to the PO-LNs (dermal
mo-DCs) and from monocytes recruited to the PO-LNs
where they differentiated into DCs (LN mo-DCs). Dermal
mo-DCs and LN mo-DCs were the DC subsets predomi-
nantly infected by L. major, and accordingly they were
the only DC subsets that expressed IAd-LACK peptide
complexes. Among de novo formed monocyte-derived
DCs, dermal mo-DCs displayed a higher capacity to
produce IL-12 and to stimulate L. major-specific T cells,
suggesting their essential role in the induction of protec-
tive T helper 1 (Th1) responses against Leishmania.Immunity 26, 519–531, April 2007 ª2007 Elsevier Inc. 519
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Changes in PO-LN DC Subpopulations
Injection of L. major in the footpad of C57BL/6 mice in-
duced an inflammatory process causing a swelling reac-
tion, both in the skin and draining PO-LNs. This inflamma-
tory reaction was detectable 24 hr after injection, reached
a maximal development after 4–5 weeks, and then de-
clined progressively. In C57BL/6 mice, this led to healing
of leishmaniasis at 5–6 weeks after infection. In contrast,
in BALB/c mice that cannot control parasite infection
and die of leishmaniasis, disease progression caused
a continuous development of the inflammatory reaction
both in the skin and PO-LNs (see Figures S1A and S1B
in the Supplemental Data available online).
In order to investigate whether L. major infection
caused quantitative and qualitative changes in the DC
subsets existing in the PO-LNs, and whether de novo
DC differentiation occurred, we first characterized the
DC subpopulations present in the PO-LNs at different
time points after infection. Uninfected PO-LN DC sub-
populations included CD8 and CD8+ DCs, Langerhans
cells (LCs), dermal DCs (dDCs), and plasmacytoid
(pDCs) (Figure 1A). These DC subsets, also found within
infected PO-LNs, essentially displayed the same pheno-
typic characteristics as previously reported (Figure 1B;
reviewed in Villadangos and Heath, 2005). We further
examined all DC-related PO-LN subpopulations at 4
weeks after infection (Figure 1B). Although CD8 and
CD8+ DCs were negative for CD86, they expressed
higher MHC II and CD40 than their control counterparts
(not shown), suggesting that they had undergone a par-
tial maturation process during infection. Interestingly,
L. major infection was paralleled by the appearance of
three new DC-related subpopulations, not detected in
control PO-LNs. These included CD11c cells express-
ing high CD11b that, based on their phenotype (Figures
1B and 1C) and previous data (Leo´n et al., 2004), corre-
sponded to monocytes, and two CD11c+ DC subsets
(DC subsets F and G; Figures 1A and 1C), with different
amounts of CD11b expression. As shown in Figure 1B,
an extensive phenotypic study was performed by corre-
lating the expression of the DC marker CD11c with cell
markers that allowed the description of the different
mouse DC subpopulations (reviewed in Ardavin, 2003).
This led to a precise definition of all PO-LN DC subsets
during L. major infection (Figure 1C) and to an accurate
calculation of the absolute number of cells within each
subset (Figure 2A). In this regard, it is important to em-
phasize, that in Figure 1A, regions A to G do not defineexactly the indicated cell subsets, because these can-
not be accurately characterized based only on the
CD11c versus CD11b correlation.
DC subsets F and G were already detectable 3 days
after infection and constituted quantitatively the main
PO-LN DC subpopulations from week 3 onward. Their
number dropped markedly at the end of the first week
but increased again from week 2 (Figures 1C and 2A;
Table S1). The phenotypic analysis of these DC subsets
revealed that DCs of subset F were Ly-6Chigh, displayed
intermediate MHC II expression, and did not express
CD86. DCs of the subset G were Ly-6Clow and expressed
high amounts of MHC II and CD86.
Figure 2A summarizes the variations in the absolute cell
number for each DC-related PO-LN subpopulation, during
L. major infection. CD8+ and CD8 DC subsets increased
significantly and progressively from day 3, reaching a
peak during week 2. After this point, the number of
CD8 DCs (that increased approximately 30-fold from
day 3 to week 2) remained unchanged until week 4,
whereas the number of CD8+ DCs (that increased aproxi-
mately 15-fold from day 3 to week 2) dropped80% from
week 2 to week 4. LCs and pDCs followed a similar kinet-
ics as did CD8 DCs. Regarding the new subsets that ap-
peared as a consequence of infection, i.e., monocytes and
the DC subsets F and G, they all dramatically increased in
number from day 1 to week 4 (40-fold for monocytes and
100-fold for DC subsets F and G), although, as pointed
out above, their number dropped markedly at the end of
the first week. At week 4 after infection, DC subsets
F and G represented 75% of all DCs present in the
PO-LNs.Macrophages, aminor population in the PO-LNs,
followed a similar kinetics as did CD8 DCs.
Thus, all DC subpopulations present in the PO-LNs in-
creased in number during the first 2 weeks of infection,
but only the new DC subsets F and G kept increasing at
weeks 3 and 4. Cell-cycle analysis of PO-LN cells at
3 weeks after infection revealed that no significant cell
proliferation was foundwithinmonocytes or DCs, whereas
up to 20%cycling lymphocytes were detected (Figure 2B).
As reported (reviewed in Sacks and Noben-Trauth, 2002),
the immune response of C57BL/6 mice against L. major
switched, between 2 and 3 weeks after infection, from
a nonprotective Th2 response toward a protective Th1 re-
sponse, as revealed by the IL-4 versus IFN-g secretion
pattern (Figure 2C). This Th2 to Th1 switch resulted in a
decrease in the number of eosinophils after week 2 (Fig-
ure 2A), whereas eosinophils increased all along the dis-
ease in BALB/c mice (not shown). Thus, the late phases
of the immune response against L. major infection wereFigure 1. Characterization of the PO-LN DC Subpopulations during L. major Infection
DC subpopulations were analyzed in the PO-LNs of C57BL/6 mice at different time points after subcutaneous infection of L. major promastigotes.
(A) Changes in the DC subpopulations present in the PO-LNs at different time points after L. major infection (A, CD8 and CD8+ DCs; B, LCs and
dDCs; C, pDCs; D, monocytes; E, macrophages; F, DC subset F; G, DC subset G, as indicated in [B] and [C]).
(B) Phenotypic analysis of PO-LNDC subpopulations at week 4 after infection. The percentage of cells with a fluorescence intensity over control stain-
ing is indicated.
(C) Definition of the DC subpopulations present in the PO-LNs at week 4 after infection based on the level of expression of the indicatedmarkers. Data
are representative of 5 independent experiments with similar results.Immunity 26, 519–531, April 2007 ª2007 Elsevier Inc. 521
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Monocyte-Derived DCs during Leishmania InfectionFigure 2. Kinetics of PO-LN Subpopulations during L. major Infection
The kinetics of the immune response against L. majorwas determined by analyzing the variations in the absolute number within the different cell pop-
ulations present in the PO-LNs at different time points after infection, the cell-cycle status of monocytes andmonocyte-derived DCs, and the T helper
response polarization.
(A) Changes in the absolute number of each PO-LN DC subpopulation along L. major infection. White arrows indicate the reduction in DC subsets
F and G occurring 1 week after infection.
(B) Cell-cycle analysis of monocytes, DC subsets F and G, and total lymphocytes from the PO-LNs at week 4 after infection. Numbers indicate the
percentage of cells in the S + G/M stages of the cell cycle as assessed by propidium iodide staining.
(C) Kinetics of Th1 (IFNg production) versus Th2 (IL-4 production) response during L. major infection in C57BL/6 and BALB/c mice.
Error bars represent the SD of triplicate cultures. Data are representative of 5 (A) and 3 (B and C) independent experiments with similar results.characterized by an important increase in monocytes and
DC subsets F and G.
Analysis of DC Subpopulations Present
in the Inflamed Skin
The phenotype of monocytes and DC subsets F and G led
us to speculate that DC subset F could represent mono-
cyte-derived DCs in an immature stage, whereas DC sub-
set G would correspond to monocyte-derived DCs that
have undergone a maturation process. This postulate
was the basis of our working hypothesis, summarized in
Figure S2, proposing that DC subset F would correspond
to immature DCs differentiated from monocytes directly
recruited to the PO-LNs. In contrast, because the pheno-
type reported for dDCs after migration to the LNs (Itano
et al., 2003) coincideswith that of DC subset G, this subset522 Immunity 26, 519–531, April 2007 ª2007 Elsevier Inc.could correspond to DCs differentiated from monocytes
recruited to the dermis that have subsequently migrated
to the PO-LNs. To demonstrate this hypothesis, we ana-
lyzed whether monocytes were recruited to the dermis
and whether monocyte-derived DCs were detected in
the dermis during L. major infection.
Dermis-infiltrating cells (identified as CD45-positive
cells) were characterized by correlating the expression of
CD11c and Ly-6C with that of CD11b, MHC II, CD86,
DEC-205, or F4/80. At week 3 after infection (correspond-
ing to thepeakof inflammation), thedermis-infiltrating cells
included monocytes, macrophages, neutrophils, and DCs
(Figure 3A). DCs could be further subdivided in Ly-6Chigh
and Ly-6Cint fractions, the latter displaying a more mature
phenotype (Figure 3B). Ly-6Cint DCs infiltrating the dermis
were phenotypically similar to subset G DCs detected in
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Monocyte-Derived DCs during Leishmania InfectionFigure 3. Analysis of Dermis-Infiltrating Cells during L. major Infection
Dermis-infiltrating cells were analyzed in the footpad of C57BL/6 mice at different time points after subcutaneous infection with L. major
promastigotes.
(A) Definition of the main cell populations present in the dermis 3 weeks after infection based on the expression of the indicated markers.
(B) Phenotypic analysis of dermis-infiltrating cell populations 4weeks after infection. The percentage of cells with a fluorescence intensity over control
staining is indicated.
(C) Relative percentage represented by each dermis-infiltrating cell population 3 weeks after infection. Data are representative of 4 independent
experiments with similar results.
(D) Changes in the absolute number of the dermis-infiltrating cell populations at different time points after infection.the PO-LNs, although the latter displayed higher MHC II
and CD86 expression. At the peak of the inflammatory re-
action, DCs constituted the most numerous cell popula-
tion, accounting for up to 35% of CD45+ dermal cells;
both macrophages and neutrophils represented 15%,
and monocytes 5% (Figure 3C). The remaining 30% in-
cluded eosinophils, T, and NK cells. The absolute number
of dermalmonocytes,macrophages,DCs, andneutrophils
increased dramatically from week 2 to 3 of infection and
decreased from week 4 (Figure 3D).
Therefore, L. major infection induced the recruitment
of monocytes to the dermis and a strong increase in theabsolute number of DCs in this location. Both processes
were coincident with the increase in the number of mono-
cytes and DC subsets F and G in the PO-LNs and with the
onset of the Th1 response. Taking into account the pheno-
type of dermal and PO-LN monocytes, DC subsets F and
G, and Ly-6Chigh and Ly-6Cint DCs found in the dermis,
our data suggest that Ly-6Cint DCs would result from par-
tial maturation of Ly-6Chigh DCs. Partially mature Ly-6Cint
DCs would complete their maturation after migration to
the PO-LNs, where they would constitute the DC subset
G. DC subset F would result from the local differentiation
of monocytes recruited to the PO-LNs.Immunity 26, 519–531, April 2007 ª2007 Elsevier Inc. 523
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Monocyte-Derived DCs during Leishmania InfectionFigure 4. Monocyte Recruitment and Differentiation during L. major Infection
In vivo differentiation of monocytes isolated from C57BL/6 Ly 5.1 Pep3b mice and transferred intravenously or subcutaneously into C57BL/6 Ly
5.2 mice at week 4 after infection with L. major, was analyzed in the dermis and PO-LNs.
(A and B) Differentiation of DCs from monocytes transferred intravenously (A) or subcutaneously (B) 4 weeks after infection, analyzed in the PO-LNs.
(C and D) Differentiation of DCs from monocytes transferred intravenously (C) or subcutaneously (D) 4 weeks after infection, analyzed in the dermis.524 Immunity 26, 519–531, April 2007 ª2007 Elsevier Inc.
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and De Novo DC Differentiation
Monocyte transfer experiments were performed to ad-
dress whether DC subsets F and G derived from mono-
cytes recruited to the PO-LNs and skin, respectively.
Monocytes from Ly-5.1+ mice were transferred, either
intravenously or subcutaneously, into Ly-5.2+ mice, 3–4
weeks after Leishmania infection, i.e., coincident with
the peak of the Th1 response. The PO-LNs and dermis
were analyzed 72 hr after monocyte transfer for the pres-
ence of Ly-5.1+ monocyte-derived cells (Figure 4A). After
intravenous (i.v.) transfer, Ly5-1+ cells present in the
PO-LNs included CD11clow, Ly-6Chigh, MHC IIint cells (pop-
ulation 1a), CD11cint, Ly-6Chigh, MHC IIint cells (population
2a), and CD11cint, Ly-6Clow, MHC IIhigh cells (population
3). Previous data (Leo´n et al., 2004) indicate that popula-
tion 1a most likely corresponds to monocytes in an early
phase of differentiation into DCs. Populations 2a and 3
displayed the same phenotype as endogenous DC sub-
sets F and G, respectively (Figure 1B). When PO-LNs
were analyzed for the presence of Ly-5.1+ cells after
monocyte s.c. transfer, only CD11cint, Ly-6Clow, MHC
IIhigh DCs, phenotypically identical to population 3 in
Figure 4A or to the endogenous DC subset G were de-
tected (Figure 4B).
Analysis of the dermis after i.v. or s.c. monocyte transfer
(Figures 4C and 4D) revealed that Ly5-1+ monocyte-
derived cells included CD11clow, Ly-6Chigh, MHC IIint cells
(population 1b), and CD11cint, Ly-6Cint-high, MHC IIint-high
cells (population 4). Population 1b was equivalent to pop-
ulation 1a found in the PO-LNs after i.v. monocyte trans-
fer. Population 4 had a phenotype equivalent to that de-
scribed for endogenous dDCs (Figures 3A and 3B) and
consequently included DCs expressing from intermediate
to high levels of Ly-6C and MHC II.
Results from monocyte transfer experiments represent
the first formal demonstration of monocyte differentiation
into DCs during an in vivo infectious process. In addition,
they strongly support that population 2a, and more likely
the DC subset F, corresponds to DCs differentiated from
monocytes recruited to the PO-LNs through high endo-
thelial venules (HEVs). Finally, these data demonstrate
that population 3, and therefore most likely the DC subset
G, correspond at least in part to DCs differentiated in the
dermis from monocytes that had subsequently migrated
to the PO-LNs through the lymphatics. Nevertheless, we
could not exclude that a fraction of cells included in pop-
ulation 3 could derive from population 2a, as a result of
a maturation process.
The analysis of the spleen (Figure 4E), an organ not
receiving afferent lymphatic vessels, revealed that cells
derived from i.v. transfer of monocytes included
CD11clow, Ly-6Chigh, MHC IIint cells (population 1c; equiv-
alent to 1a and 1b) and CD11cint, Ly-6Chigh, MHC IIint cells
(population 2b; equivalent to 2a), but not cells correspond-ing to population 3 (and therefore to DC subset G). This re-
sult favors the hypothesis that DC subset F corresponds
to DCs differentiated from monocytes recruited from the
blood to the PO-LNs. Intravenous transfer of monocytes
also appeared to generate splenic DCs equivalent to en-
dogenous CD8+ and CD8 DCs (population 5).
In conclusion, our data derived from monocyte-transfer
assays support that infection-induced inflammatory pro-
cesses promote the recruitment to antigen-capture areas
and associated lymphoid organs of monocytes that sub-
sequently differentiate locally into DCs. According to our
working hypothesis, de novo formed DCs found in the
PO-LNs would include DCs generated in situ from mono-
cytes recruited through the HEVs (that will be referred to
as LN mo-DCs), and DCs differentiated from monocytes
recruited to the dermis through dermal venules that would
have undergone a process of maturation and migration to
the PO-LNs (these DCs will be referred to as dermal
mo-DCs).
Analysis of Cell Subsets Infected by L. major
The fact that de novo formed dermal mo-DC and LN mo-
DC subpopulations increased dramatically along weeks 3
and 4 of infection, concomitantly with the Th2-Th1 switch,
prompted us to investigate their role in the induction of T
cell immunity against L. major. In this sense, it has been
demonstrated that protective immune responses against
L. major rely on the induction of Th1 responses against
the L. major immunodominant LACK antigen that in turn
involve the presentation by infected DCs of a LACK-
derived peptide in the context of MHC II molecules to
specific CD4+ T cells (Mougneau et al., 1995).
We first analyzed which PO-LN DC subsets were in-
fected by injecting L. major red fluorescent DsRed+ pro-
mastigotes, which allow the detection of the cells having
internalized the parasite. In the PO-LNs, 1% of the cells
were infected at week 4 after infection, and those included
essentially monocytes, macrophages, LN mo-DCs, and
dermal mo-DCs (Figure 5A). The percentage of infected
cells within each of these subsets was5%–7%,whereas
up to 20%ofmacrophageswere infected. The percentage
of infected cells among CD8 DCs, CD8+ DCs, LCs,
pDCs, andCD11b-negative cells (including T cells, B cells,
andNK cells) was undetectable (Figure 5B). Analysis of the
footpad revealed that the percentage of cells infected
among dermal-infiltrating cells was significantly higher
than in the PO-LNs (50%). These included monocytes,
macrophages, dermal mo-DCs, neutrophils, and eosino-
phils. A high percentage of all these cell types was in-
fected: 40% of dermal monocytes and eosinophils,
70% of dermal macrophages and neutrophils, and 90%
of dermal mo-DCs (Figure 5C). In contrast, less than 5%
of dermal CD11b-negative cells (mainly T cells and NK
cells) were infected. With regard to dermal mo-DCs, the
fact that more than 90% of them were infected in the(E) Differentiation and phenotype of DCs derived from monocytes transferred intravenously 4 weeks after infection, analyzed in the spleen. Numbers
represent the percentage of cells with a fluorescence intensity over control staining.
Data are representative of 4 (A–D) and 3 (E) independent experiments with similar results.Immunity 26, 519–531, April 2007 ª2007 Elsevier Inc. 525
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Monocyte-Derived DCs during Leishmania InfectionFigure 5. Analysis of DC Subsets Infected by L. major
Cells infected by L. majorwere analyzed in the PO-LNs and dermis of C57BL/6 mice 4 weeks after subcutaneous injection of red fluorescent DsRed+
L. major promastigotes.
(A) Characterization of the PO-LN cell populations infected by L. major at week 4 after injection of red fluorescent parasites; infected cells were an-
alyzed after gating on red fluorescent cells.
(B) Absolute number and relative proportion of cells infected by L. major for the indicated PO-LNs cell types, at week 4 after injection of red fluorescent
parasites.
(C) Absolute number and relative proportion of cells infected by L. major for the indicated dermal cell types, at week 4 after injection of red fluorescent
parasites.
(D) Expression of the chemokine receptor CCR7 by PO-LN and skin dermal mo-DCs at week 4 after infection. The percentage of cells with a fluores-
cence intensity over control staining is indicated. Data are representative of 4 independent experiments with similar results.skin, whereas only 10% were infected in the PO-LNs,
could imply that noninfected dermal mo-DCs migrated
more efficiently to the PO-LNs than those infected. In
support of this hypothesis, whereas all dermal mo-DCs
present in the PO-LNs were positive for the chemokine
receptor CCR7 (controlling DC migration to peripheral
LNs), among dermal mo-DCs present in the skin, those
not infected by L. major were CCR7+, whereas 60% of
those infected did not express this receptor (Figure 5D).
Alternatively, it could be hypothesized that the lower per-
centage of infected dermal mo-DCs found in the PO-LNs
could be related to a stronger microbicidal potential deter-
mined by DC maturation, as reported for infected macro-526 Immunity 26, 519–531, April 2007 ª2007 Elsevier Inc.phages after activation (reviewed in Sacks and Noben-
Trauth, 2002).
Capacity of De Novo FormedMonocyte-Derived DCs
to Induce T Cell Responses against L. major
The finding that, among DC subsets present in the PO-
LNs at late phases of infection, only LN mo-DCs and der-
malmo-DCswere infected by L.major suggests that these
de novo formed monocyte-derived DCs could be
responsible for T cell immunity against the parasite. To
address this issue, we determined the capacity of LN
mo-DCs and dermal mo-DCs, purified from PO-LNs at
4 weeks after infection, to induce T cell responses against
Immunity
Monocyte-Derived DCs during Leishmania InfectionFigure 6. Analysis of the Potential of Monocyte-Derived DCs to Induce L. major-Specific T Cell Responses
LN mo-DCs and dermal mo-DCs purified from PO-LNs of C57BL/6 (A and B) or B10.D2 (C–E) mice, at 4 weeks after infection, were anlayzed for their
capacity to induce T cell responses against L. major.
(A) Capacity of LN mo-DCs versus dermal mo-DCs to induce IFNg and IL-4 secretion by CD4+ and CD8+ T cells; DCs and T cells were isolated from
the PO-LNs of C57BL/6 mice at week 4 after infection. Error bars represent the SD of triplicate cultures.
(B) IL-12 p70 production by LNmo-DCs and dermal mo-DCs isolated fromC57BL/6 mice at week 4 after infection determined by intracellular staining
with IL-12 p70 antibodies.
(C) Capacity of dermal mo-DCs versus LNmo-DCs isolated from the PO-LNs of B10.D2 mice, at week 4 after infection, to stimulate the production of
IL-2 by the LACK peptide 158-163-specific LMR7.5 T cell hybridoma. Error bars represent the SD of triplicate cultures.
(D) Detection of IAd-LACK complexes by the mAb 2C44 at the cell surface of the indicated DC subsets isolated from the PO-LNs of B10.D2 mice, at
week 4 after infection.
(E) Correlation between IAd-LACK expression and L. major infection analyzed in the indicated DC subsets isolated from the PO-LNs of B10.D2 mice,
at week 4 after infection. The percentage of cells with a fluorescence intensity over control staining is indicated.
Data are representative of 4 (A and B) and 3 (C–E) independent experiments with similar results.L. major. We first analyzed their potential to induce the se-
cretion of Th1 and Th2 cytokines by preactivated CD4+ or
CD8+ T cells. Dermal mo-DCs were more efficient than LN
mo-DCs in promoting IFNg production by CD4+ and CD8+
T cells (Figure 6A). The higher T cell stimulatory potential of
dermal mo-DCs was likely due to their higher MHC II, and
particularly CD86 expression. Low amounts of IL-4 pro-
duction by CD4+ T cells were induced either by LN
mo-DCs or dermal mo-DCs, indicating that both DC sub-
sets promoted a Th1 bias of the response. To ascertain
whether the stronger IFNg production induced by dermal
mo-DCs correlated with differences in IL-12 production,
PO-LN LN mo-DCs and dermal mo-DCs were analyzed
ex vivo for IL-12 production by intracellular staining
at week 4 after infection. Approximately 10% dermalmo-DCs were positive for IL-12, whereas only 2%–3%
of LN mo-DCs produced this cytokine (Figure 6B). Pro-
duction of IL-12 by other PO-LN DC subsets was unde-
tectable (not shown). To determine whether this differen-
tial ex vivo IL-12 production potential implied a stronger
IL-12 production after in vitro stimulation, dermal mo-
DCs and LN mo-DCs were cultured in the absence or
presence of LPS. Culture in the absence of LPS promoted
a moderate increase in IL-12+ dermal mo-DCs and LN
mo-DCs that was further increased after LPS treatment.
The ratio between IL-12+ dermal mo-DCs and IL-12+ LN
mo-DCs was similar in all the experimental conditions
analyzed, indicating that the former have a higher potential
to produce IL-12 before and after in vitro activation. Thus,
our data on induction of IFN-g production by CD4+ T cellsImmunity 26, 519–531, April 2007 ª2007 Elsevier Inc. 527
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play a major role in the induction of L. major-specific Th1
responses.
To provide a stronger support to this hypothesis, we an-
alyzed the capacity of dermal mo-DCs and LN mo-DCs,
isolated fromweek 4 PO-LNs, to stimulate IL-2 production
by the LMR7.5 T cell hybridoma, specific for the LACK
antigen-derived 158-163 (LACK 158-163 peptide), in the
context of I-Ad MHC II molecules. For these experiments,
B10.D2 mice (I-Ad) were used, because C57BL/6 mice
(used in this report for all the other experiments) express
the I-Ab MHC allele nonrecognized by LMR7.5 cells.
B10.D2 and C57BL/6 mice develop a similar immune re-
sponse against L. major, regarding kinetics of infection,
DC subsets infected, Th1 bias of the response, monocyte
recruitment, and differentiation and DC subsets present in
the PO-LNs and dermis (data not shown). As shown in
Figure 6C, dermal mo-DCs, but not LN mo-DCs, induced
IL-2 production by LMR7.5 cells. Positive control experi-
ments revealed that LACK 158-163 peptide-pulsed der-
mal mo-DCs and LNmo-DCs could induce the stimulation
of LMR7.5 T cells, although dermal mo-DCs were more
effective. We next analyzed the potential of the different
PO-LN DC subsets to present IAd-LACK complexes to
CD4+-specific T cells, at week 4 after infection. For this
purpose, we used the 2C44 mAb that specifically recog-
nizes MHC II (IAd)-LACK 158-163 peptide (IAd-LACK)
complexes at the cell surface. Only LN mo-DCs and der-
mal mo-DCs expressed IAd-LACK complexes at the cell
surface (Figure 6D); this result is in accordance with our
data on susceptibility to infection revealing that LN mo-
DCs and dermal mo-DCs were specifically infected by
L. major. The finding that none of the other DC subsets
analyzed (i.e., CD8 DCs, CD8+ DCs, LCs, and pDCs) ex-
pressed IAd-LACK complexes excluded the possibility
that any of these DC subsets had acquired the capacity
to present IAd-LACK complexes as a result of IAd-LACK
complex transfer from infected LN mo-DCs or dermal
mo-DCs to noninfected DCs. These data indicated that
only those DC subsets that were susceptible to L. major
infection had the capacity to present LACK-derived pep-
tides, and conversely that DCs expressing IAd-LACK com-
plexes were infected by the parasite. To further support
this hypothesis, the correlation between IAd-LACK ex-
pression and infection by L. major was analyzed 4 weeks
after infection of B10.D2 mice with red fluorescent para-
sites. As shown in Figure 6E, LN mo-DCs and dermal
mo-DCs were the only DC subsets that were infected by
L. major and expressed IAd-LACK complexes. These ex-
periments also demonstrate that all the LN mo-DCs and
dermal mo-DCs expressing IAd-LACK complexes were
infected by L. major. Taken together, our data on the sus-
ceptibility to infection, expression of IAd-LACK complexes
at the cell surface, IL-12 production potential, and T cell
stimulatory capacity strongly support the concept that
dermal mo-DCs that derive from monocytes recruited to
the infection site and that have migrated to the PO-LNs
are essential for the induction of L. major-specific,
Th1-biased T cell responses.528 Immunity 26, 519–531, April 2007 ª2007 Elsevier Inc.DISCUSSION
Results presented in this report provide a formal demon-
stration of the potential of monocytes to differentiate into
DCs in vivo during infectious processes, the de novo local
differentiation of DCs in inflammatory sites of infection and
dLNs, and the essential role that inflammatory de novo
formed monocyte-derived DCs can play in the induction
of T cell responses against pathogens.
Although the capacity of monocytes to differentiate into
DCs during in vivo infection is controversial, a number of
studies had described the accumulation of DCs during in-
fectious processes, or shown in noninfectious inflamma-
tory models that monocytes can differentiate into DCs
in vivo. During Listeria monocytogenes infection, de novo
generation of splenic DCs was reported, and newly
formed DCs were proposed to derive from monocytes
recruited to the spleen (Serbina et al., 2003). Adjuvant-
induced DC accumulation in epithelial tissues was pre-
ceded by CCR6- and CCL20-dependent monocyte re-
cruitment; these newly recruited DCs were essential for
CD8+ T cell crosspriming against a protein antigen (Le
Borgne et al., 2006). In contrast, experiments aiming to re-
produce an infection-mediated inflammatory process,
based on the s.c. injection of latex microspheres (Ran-
dolph et al., 1999), supported that cutaneous inflam-
matorymonocytes differentiated locally into DCs that sub-
sequenlty migrated to the dLNs. Two later studies have
reported the differentiation of monocytes into DCs in the
peritoneal cavity (Geissmann et al., 2003) and spleen
(Naik et al., 2006), respectively, during experimental in-
flammatory reactions. However, the concept that mono-
cytes could behave as DC precursors during infection
was challenged by a report demonstrating that monocyte
differentiation into DCs was blocked if bacteria were pres-
ent in the area of injection of the latex microspheres (Rotta
et al., 2003). These results are in accordance with in vitro
data showing that activation of monocytes by pathogens
or TLR ligands blocks their capacity to differentiate into
DCs and promotes their differentiation into macrophages
(reviewed in Palucka and Banchereau, 1999). Thus, it
could also be speculated that during L. major infection,
monocytes could differentiate into DCs after engagement
of GM-CSF receptors in the absence of interaction of
parasites with TLR receptors on the monocytes. Differen-
tiation of dermal mo-DCs and LN mo-DCs from mono-
cytes most likely occurred because of low parasitemia
during late phases of L. major infection in C57BL/6 mice.
In agreement with the inhibition of DC differentiation
from monocytes that occurred in the presence of bacteria
(Rotta et al., 2003), blockade of monocyte differentiation
into DCs determined by parasite-induced monocyte acti-
vation could also be the basis for our observation of the
strong reduction in dermal mo-DCs and LN mo-DCs after
the first week of infection.
On the other hand, our results indicate that the appear-
ance and increase in number of dermal mo-DCs and LN
mo-DCs occurring during L. major infection was due to
continuous de novo local differentiation of DCs from
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the recruitment of preformed DCs. In this regard, an in-
crease in the number of DCs in infection-induced inflam-
matory areas and dLNs has been described in three differ-
ent reports (Martin et al., 2002; Yoneyama et al., 2001;
Zhao et al., 2003). Importantly, these studies did not ad-
dress whether DC increase was due to DC recruitment
or to local differentiation of DCs. A possible role for mono-
cytes in this process was supported by previous reports
describing the generation of splenic DCs during Listeria
infection (Serbina et al., 2003) and adjuvant-induced ac-
cumulation of DCs in epithelial tissues (Le Borgne et al.,
2006). Interestingly, monocytes have been demonstrated
to represent LC precursors both under steady state and
during inflammation (Ginhoux et al., 2006; Merad et al.,
2002).
L. major infection determined an important increase in
pDC, CD8 DC, and CD8+ DC subpopulations, although
their role remains to be addressed. In contrast to conven-
tional DCs, pDCs can be recruited to lymphoid organs
and inflammatory areas (Bendriss-Vermare et al., 2004; Di-
acovo et al., 2005), suggesting that the increase in pDCs
occurring during L. major infection could result from blood
pDC recruitment to the PO-LNs, althoughwhether de novo
local differentiation of pDCs occurred has to be analyzed.
Regarding CD8 and CD8+ DCs, whether during L. major
infection these DC subsets derived from monocytes or
other DC precursors has to be clarified. Our results chal-
lenge the hypothesis that DCs generated during inflamma-
tion constitute an independent DC category, unrelated to
resident DCs and pDCs. In this sense, DCs generated
during pathogen-induced inflammatory reactions would
include monocyte-derived DCs subsets not found in non-
inflammatory conditions (such as dermal mo-DCs and LN
mo-DCs), aswell as resident DC subsets existing in control
conditions (i.e., CD8 DCs, CD8+ DCs, and pDCs).
Dermal mo-DCs and LN mo-DCs were, together with
monocytes and macrophages, the cell subsets predomi-
nantly infected by L. major. This observation is in agree-
ment with previous studies demonstrating that L. major in-
ternalization is mediated by complement receptors, such
as CD11b and CR1, mainly expressed by cells of the
monocytic-macrophage lineage, that have the capacity
to sustain parasite replication (reviewed in Sacks and
Noben-Trauth, 2002). It can be speculated that dDCs in-
fected together with dermal monocytes andmacrophages
during early phases of infectionwould release amastigotes
that would in turn infect, in the dermis, newly recruited
monocytes and de novo formed dermal mo-DCs. Trans-
mission of infection to monocytes recruited to the PO-
LNs and to newly formed LN mo-DCs would occur after
migration of infected dDCs and dermalmo-DCs. However,
we cannot exclude that at early infection phases free pro-
mastigotes could reach the PO-LNs, in agreement with
recent reports (Baldwin et al., 2004; Iezzi et al., 2006).
According to this hypothesis, within the PO-LNs, a propor-
tion of both dermal mo-DCs and LN mo-DCs were contin-
uously infected, from week 2 until the last phases of infec-
tion. Infection was not detectable in the other PO-LN DCsubsets, i.e., pDCs, CD8 DCs, and CD8+ DCs. Accord-
ingly, IAd-LACK complexes were detected exclusively on
dermal mo-DCs and LN mo-DCs, which consequently
were the only DCs endowed with the potential to activate
LACK-specific T cells. These data suggest that dermal
mo-DCs are responsible for the induction of protective T
cell responses against L. major, and therefore that inflam-
matory, de novo formed, monocyte-derived DCs could
have an essential role in T cell immunity against pathogens.
Recent studies have addressed the identity of the DC
subpopulations responsible for immune responses
against pathogens. A role for either LCs, dermal DCs, in-
terstitial DCs, CD8 DCs, or CD8+ DCs in the induction
of T cell immunity against viral, bacterial, or parasitic infec-
tions has been reported, although data were in some
cases contradictory, probably resulting in part from the
experimental models employed (reviewed in Villadangos
and Heath, 2005). Concerning DCs responsible for the in-
duction of T cell responses against L. major, although LCs
were considered to play a major role in this process (Moll
et al., 1993), mice not expressing MHC class II molecules
on LCs displayed a healing phenotype (Lemos et al.,
2004). On the other hand, T cell immunity against L. major
was proposed to depend on resident CD11b+ DCs (Filippi
et al., 2003), which would have been infected by parasites
transported to the PO-LNs through the lymphatics (Iezzi
et al., 2006). Importantly, based on their phenotype, these
so-called resident DCs could correspond to LN mo-DCs.
Discrepancy between these reports and our data sup-
porting an essential role for migratory dermal mo-DCs in
T cell immunity against L. major probably reflects that in
the reports cited above, the early phases of infection
were analyzed, whereas our results refer to later phases
of infection that determined the Th2-Th1 switch in the T
cell response. It is important to take into account that
the experimental model employed in most reports on
L. major infection (including the articles cited above and
this report) involved supraphysiologic parasite doses.
Thus, at early phases of infection, free parasites could
gain access to the dLNs and infect resident DCs, whereas
at late phases of infection, amastigotes released in the
dermis from previously infected cells would infect dermal
mo-DCs, which in turn would be responsible for carrying
the infection to the LNs and inducing the activation of
L. major-specific Th1 responses. Based on experiments
performed with low parasite doses, reproducing more
closely the physiological infection (Belkaid et al., 2000), it
has been postulated that at high parasite doses, the early
phases of infection involved an anomalous transport of
the parasite to the LNs and a nonphysiologic immune re-
sponse. In contrast, even after injection of high parasite
doses, the late phases of infection would be comparable
to the physiogical infection conditions.
In summary, our data strongly suggest that under phys-
iological conditions, dermal mo-DCs, which could repre-
sent the inflammatory counterparts of dDCs, were respon-
sible for the induction of protective Th1 responses against
L. major. Interestingly, an essential role in the induction of
virus-specific T cell responses for dDCs or interstitial DCsImmunity 26, 519–531, April 2007 ª2007 Elsevier Inc. 529
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has also been reported during infection by influenza virus
and herpes virus (Allan et al., 2006; Zhao et al., 2003). The
new concept of de novo local DC differentiation in inflam-
matory foci opens a new area of research related to the
influence of local mediators on the acquisition of the
functional specialization of newly formed DCs.
EXPERIMENTAL PROCEDURES
C57BL/6, BALB/c, and B10.D2 mice were purchased from Harlan
(Bicester, UK). C57BL/6 Ly 5.1 Pep3bmice were purchased from Jack-
son (Bar Harbor, ME) and bred under SPF conditions. For monocyte
transfers, donors were C57BL/6 Ly 5.1 Pep3b mice and recipients
were C57 BL/6 Ly 5.2 mice. L. major promastigotes (WHOM/IR/173
strain) and red fluorescent DsRed+ L. major promastigotes (kindly
provided by N. Glaichenhaus, Universite´ de Nice-Sophia Antipolis,
France) were grown as described (Filippi et al., 2003). Mice were
injected with 2 3 106 stationary-phase promastigotes in the hind
footpad. Lesion size was determined by measuring the thickness of
the footpad at the site of injection.
A detailed description of themethods used for the preparation of cell
suspensions and the purification of monocytes, DC subpopulations,
and T cells is included in the Supplemental Data. In transfer experi-
ments, 3–5 3 106 purified monocytes were injected intravenously or
subcutaneously into C57 BL/6 Ly 5.2 recipient mice that were infected
3–4 weeks before with L. major. Cells derived from transferred mono-
cytes were analyzed as Ly-5.1+ cells by flow cytometry 72 hr after
transfer, in the dermis, PO-LNs, and spleen.
For the analysis of the kinetics of Th1/Th2 response (Figure 2C),
CD4+ T cells from the PO-LNs of L. major-infected C57BL/6 or
BALB/c mice were analyzed for the production of IFNg and IL-4, after
48 hr stimulation with anti-CD33 (clone 145-2C11; Pharmingen) and
anti-CD28 (37.51; Pharmingen) mAbs, by means of mouse IFNg and
IL-4 ELISA kits (Pharmingen).
For the analysis of the capacity of LN mo-DCs and dermal mo-DCs
to induce the secretion of IFNg and IL-4 by preactivated CD4+ or CD8+
T cells (Figure 6A), CD4+ and CD8+ T cells, as well as dermal mo-DCs
and LN mo-DCs, were isolated from the PO-LNs of C57BL/6 mice at
week 4 after infection, cocultured at a 10:1 ratio for 96 hr, and analyzed
for the production IFNg and IL-4 by ELISA.
For the analysis of the capacity of LN mo-DCs and dermal mo-DCs
to stimulate the LACK 158-163 peptide-specific T cell hybridoma
LMR7.5, LMR7.5 cells (kindly provided by N. Glaichenhaus, Universite´
de Nice-Sophia Antipolis) were cocultured with dermal mo-DCs or LN
mo-DCs from PO-LNs of B10.D2 mice at week 4 after infection, at a
5:1 ratio for 24 hr, in the absence or presence of 1 mM LACK 158-163
peptide, and analyzed for the production IL-2 with a mouse IL-2 ELISA
kit (Pharmingen).
Flow cytometry analysis of PO-LN and skin cell subpopulations
was performed after triple or quadruple staining by correlating Ly-6C,
CD11b, and CD11c expression (or alternatively DEC-205, MHC II,
and CD11c expression) with the expression of CD40, CD86, B220,
CD4, CD8a, F4/80, CD45, Ly-5.1, CCR5, CCR7, IAd-LACK complexes,
or IL-12 p40/p70. A detailed description of the flow cytometrymethods
employed is included in the Supplemental Data.
Supplemental Data
Supplemental Data include two figures, one table, and Experimental
Procedures and can be found with this article online at http://www.
immunity.com/cgi/content/full/26/4/519/DC1/.
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